Américo J. S. Alves,
João A. D. Silvestre and
Teresa M. V. D. Pinho e Melo*
University of Coimbra, Coimbra Chemistry Centre-Institute of Molecular Sciences and Department of Chemistry, 3004-535 Coimbra, Portugal. E-mail: tmelo@ci.uc.pt
First published on 28th October 2022
The first examples of the diastereoselective 1,3-dipolar cycloaddition reaction of nitrile oxides and 6-alkylidene penicillanates leading to chiral spiroisoxazoline-penicillanates are reported. The synthesis of this new type of penicillanate involved the selective generation of two consecutive stereogenic centers, including a quaternary chiral center. Furthermore, the present work also describes the outcomes of these 1,3-dipolar cycloaddition reactions under three distinct reaction conditions (conventional heating, microwave irradiation and continuous flow). The successful use of the continuous flow technique as well as the proper selection of the reaction media allowed the development of a sustainable route to chiral spiroisoxazoline-penicillanates.
The above-mentioned properties of β-lactams and spiro-β-lactams have attracted the interest of organic and medicinal chemists. Thus, many researchers have turned their focus to the development of alternative synthetic approaches aiming at the synthesis of novel spiro-β-lactam derivatives.3 The synthesis of chiral spirocyclic β-lactams derived from 6-aminopenicillanic acid (6-APA) has been explored by our research group, leading to a library of chiral spiro-β-lactams with significant structural diversity. Among the synthesized spiro-β-lactams, several were identified with potent activity against both HIV and Plasmodium, the causative agents of AIDS and malaria, respectively (Fig. 1).4,5 Infections by HIV and Plasmodium remain serious public health problems, preventing economic and social progress in developing countries. The identification of spiro-β-lactams with potent activity against both infectious agents is particularly relevant due to considerable geographic overlap between HIV and Plasmodium, mainly in sub-Saharan Africa where co-infection is common, and the concerns regarding possible drug–drug interactions in patients receiving malaria and HIV treatment concomitantly.
The spiro-β-lactams synthesized by our research group were obtained by exploring 1,3-dipolar cycloaddition and [3 + 2] annulation reactions of 6-diazopenicillanates and 6-alkylidene penicillanates allowing the synthesis of novel chiral spiropenicillanates containing carbo- or heterocyclic rings, spiro-fused to the penicillin core.4,5 Using 6-alkylidenepenicillanates as 2π-component, the phosphane-catalyzed [3 + 2] annulation with allenoates or 2-butynoates, led to chiral spirocyclopentene-β-lactams,4b,5b,c whereas 1,3-dipolar cycloaddition reactions with diazo compounds and nitrones afforded spiropyrazoline-penicillanates and spiroisoxazolidine-penicillanates, respectively (Scheme 1).5d,e
The [3 + 2] nitrile oxide-alkene cycloaddition is an important and versatile synthetic route for the construction of isoxazoline rings.6 An important subclass of isoxazolines are the spiroisoxazolines, whose structural motif is present in natural occurring7 and synthetic compounds with biological activity, such as anticancer,7a,c,8 antibacterial,7b antimalarial,9 or antiviral activity.10
Despite the known reports on the construction of the spiroisoxazoline core, to the best of our knowledge, few of them were dedicated to alkylidene-β-lactams. In late 80 s, Corbett and co-workers reported the synthesis of spirocarbapenems, from the 1,3-dipolar cycloaddition reaction of the corresponding alkylidene-carbapenem with a nitrile oxide.11 Later, Otto and Liebscher's teams have explored the synthesis of spiro-β-lactams via 1,3-dipolar cycloaddition of nitrile oxides to α-alkylidene-β-monolactams.12 Nevertheless, none of these studies were focused on the reactivity of alkylidenepenicillanates.
We envisaged that extending the library of spiropenicillanates by adding an isoxazoline ring, spiro-fused to the penicillin core's lactam ring, could lead to interesting new scaffolds with potential biological activity. In this context, the present work focused on the 1,3-dipolar cycloaddition reaction of a 6-alkylidenepenicillanate with a diversity of nitrile oxides as an approach to the first reported examples of chiral spiroisoxazoline-penicillanates, using batch, microwave irradiation and continuous flow techniques.
The 1,3-dipolar cycloaddition reaction of nitrile oxide 4a, generated in situ from benzaldehyde hydroximoyl chloride 3a by the action of potassium carbonate, with 6-(Z)-(benzoylmethylene)penicillanate 5 was studied for the optimization of the batch and microwave-induced reaction conditions (Table 1). The use of an inorganic base ensures a slow dehydrohalogenation of hydroximoyl chlorides 3, allowing a controlled formation of the corresponding nitrile oxide 4 which readily reacts with the desired dipolarophile. Thus, the reaction of the transient nitrile oxide 4a with 6-(Z)-(benzoylmethylidene)penicillanate 5 was carried out in ethyl acetate at room temperature for 7.5 h affording compound 6a as major product in 60% yield. From this reaction an inseparable mixture of compounds 7a and 8a was also isolated in 32% yield (66:34 ratio) (entry 1). The increase of the reaction time to 24 h was counterproductive regarding the overall yield but led to compound 6a as single product isolated in 49% yield (entry 2). However, better results were obtained by increasing the temperature. Carrying out the reaction of 4a with 5 under refluxing ethyl acetate the desired products were obtained in excellent overall yield (97%) with a good selectivity for compound 6a which was isolated in 59% yield (entry 3). Curiously, the same overall yield was obtained by performing the reaction in toluene at 80 °C (entry 4) with a slight increase in the yield of 6a (entry 3: 59% vs. entry 4: 65%) and without the formation of 8a. Additionally, an alternative base for the dehydrohalogenation of hydroximoyl chloride 3a was also explored. Performing the reaction in the presence of triethylamine, the target spiro-β-lactams could also be obtained by carrying out the reaction either in ethyl acetate (in excellent overall yield, entry 5) or in toluene (in moderate overall yield, entry 6).
Entry | Base | Solvent | Reaction conditions | Isolated yields (ratio)a | Overall yield | ||
---|---|---|---|---|---|---|---|
a Ratio determined by 1H NMR.b Trace amount of 6a. | |||||||
Batch | 1 | K2CO3 | AcOEt | r.t., 7.5 h | 6a, 60% | 7a/8a, 32% (66:34) | 92% |
2 | K2CO3 | AcOEt | r.t., 24 h | 6a, 49% | — | 49% | |
3 | K2CO3 | AcOEt | Reflux, 5 h | 6a, 59% | 7a/8a, 38% (84:16) | 97% | |
4 | K2CO3 | Toluene | 80 °C, 4 h | 6a, 65% | 7a, 32% | 97% | |
5 | NEt3 | AcOEt | r.t., 24 h | 6a, 47% | 7a/8a, 51% (63:37) | 98% | |
6 | NEt3 | Toluene | 80 °C, 4 h | 6a, 11% | 7a/8a, 37% (38:62) | 48% | |
MW | 7 | K2CO3 | AcOEt | 80 °C, 30 min | 6a, 32% | 7a, 28% | 60% |
8 | K2CO3 | AcOEt | 80 °C, 1 h | 6a, 35% | 7a, 34% | 69% | |
9 | K2CO3 | Toluene | 80 °C, 30 min | 6a, 42% | 7a, 32% | 74% | |
10 | K2CO3 | Toluene | 120 °C, 10 min | — | — | —b | |
11 | NEt3 | Toluene | 80 °C, 30 min | Complex mixture | — |
The reaction was also carried out under microwave irradiation (entries 7–11). It was observed that carrying out the reaction in ethyl acetate under microwave irradiation for 30 minutes at 80 °C afforded compounds 6a and 7a in 32% and 28% yield, respectively (entry 7). The yields were slightly improved using the same conditions for 1 hour, giving products 6a and 7a in 35% and 34% yield, respectively (entry 8). Changing the reaction solvent to toluene allowed the synthesis of 6a and 7a in 74% overall yield after 30 minutes of microwave irradiation at 80 °C, with compound 6a being obtained as major product in 42% yield (entry 9). On the other hand, by increasing the temperature to 120 °C for 10 min, the consumption of the reagents was observed, but only a trace amount of 6a was detected (entry 10). Finally, carrying out the microwave-induced reaction in toluene at 80 °C for 30 min using triethylamine as the dehydrohalogenating agent, a complex mixture was obtained. It should be noted that the cycloaddition reaction between alkylidenepenicillanate 5 and nitrile oxide 4a under microwave irradiation proved to be more selective, without the formation of spiro-β-lactam 8a.
The structural assignment of compounds 6a and 7a was supported by one and two-dimensional NMR spectra (1H NMR, 13C NMR and HSQC; see ESI†). As expected, the 1H NMR spectrum of derivatives 6a and 7a show signals corresponding to two methyl groups from the penicillanate core, protons corresponding to aromatic protons and to the benzhydryl proton (CHPh2, 6a: 6.98 ppm; 7a: 6.93 ppm). The 1H NMR and HSQC spectra allowed us to assign the signals corresponding to protons H-3, H-5 of the penicillanate core and the proton of the isoxazoline ring of both compounds (Fig. 2). For compound 6a the following chemical shifts were observed: H-3 at 4.65 ppm, H-5 at 5.86 ppm and isoxazoline proton at 6.17 ppm. Major difference was observed for the proton of the isoxazoline ring in the case of compound 7a with a chemical shift of 5.67 ppm. This difference can be explained by the presence of an oxygen atom in a vicinal position to the proton in compound 6a which promotes a downfield shift. Additionally, from the HSQC spectrum it was possible to confirm the assignment of the spirocyclic carbon of both spiro-β-lactams (6a: 76.6 ppm; 7a: 102.0 ppm). The difference in the chemical shift of the spirocyclic carbons of these two regioisomers can be explained considering that only in the case of compound 7a is the oxygen atom attached to the spirocyclic carbon. This NMR data is in agreement with the proposed structures of spiro-β-lactams 6a and 7a resulting from opposite regioselectivity, with 6a and 7a being a spiro[isoxazoline-4′,6-penicillanate] (major) and a spiro[isoxazoline-5′,6-penicillanate], respectively. It is known that due to the bicyclic β-lactam-thiazolidine ring system of the penicillin core which exists in a butterfly-like structure, the approach of a given reactant usually occurs by the convex face (α-side) of the penicillin derivative.3–5 This is in agreement with the observed stereoselectivity, with both compounds 6a and 7a resulting from the addition of the dipole to the less sterically hindered α-side of the penicillanates. The stereoselectivity observed in the formation of compound 8a can be rationalized by an approach of the dipole through the β-side of the penicillanate, with the regioselective formation of the cycloadduct where the dipole's oxygen adds to the forthcoming spirocyclic carbon. The 13C chemical shift of the spirocyclic carbons are similar for compounds 7a and 8a (7a: 102.2 ppm; 8a: 100.1 ppm), as expected for diastereoisomers with the same regiochemistry.
Fig. 2 Structures of selected spiro-β-lactams highlighting the most relevant 1H and 13C chemical shifts for the stereochemistry assignment. |
The same stereo- and regioselectivity was previously described by Corbett, while exploring the 1,3-dipolar cycloaddition reaction of nitrile oxides with an alkylidene-carbapenem, aiming at the synthesis of spiroisoxazoline-carbapenem.11 In this work, it was observed that three products were obtained from this cycloaddition reaction. Two of them were the expected cycloadducts from the addition of the dipole to the α-side of the carbapenem: one results from the attack of the dipole's oxygen to the terminal carbon of the exocyclic double bond of the alkylidene (major product) and the other from the addition of the dipole's oxygen to the forthcoming spirocyclic carbon. The formation of a third cycloadduct was also observed, a diastereoisomer formed by the addition of the nitrile oxide to the β-side. It should be noted that the carbapenem bicyclic system is similar to the penicillanic core in terms of preferred conformation, leading to a more favorable addition of incoming reactants by the α-face.
Although a small difference was observed in the isolated yields of products of the 1,3-dipolar cycloaddition of 6-(Z)-(benzoylmethylene)penicillanate and phenyl-nitrile carrying out the reactions in ethyl acetate or in toluene, ethyl acetate was selected for further studies since it is a “greener” solvent than toluene.13 On the other hand, potassium carbonate was selected over triethylamine also aiming at developing a more sustainable synthetic methodology.
Next, we extended the study of the reactivity of 6-(Z)-(benzoylmethylidene)penicillanate (5) to other nitrile oxides under batch and microwave irradiation optimized reaction conditions. However, reactions carried out under conventional heating were monitored by TLC and the reaction time determined by the total consumption of alkylidenepenicillanate 5, ranging from 15 minutes to 8 hours.
The 1,3-dipolar cycloaddition reactions with nitrile oxides bearing electron-withdrawing and electron-donating substituents at para-position of the phenyl ring were explored (Table 2). To our delight, both types of dipole activation led to the expected cycloadducts, with pure chiral spiroisoxazoline-β-lactams 6b–f being obtained as major products, in yields ranging from 49–72% and 31–47%, under conventional heating and microwave irradiation, respectively (entries 1–12).
Entry | 4 | R | Methodology | Reaction time (h) | Isolated yields (ratio)a | Overall yield | |
---|---|---|---|---|---|---|---|
a Ratio determined by 1H NMR. | |||||||
1 | 4b | p-FC6H4 | Batch | 6 | 6b, 72% | 7b, trace amounts | 72% |
2 | 4b | p-FC6H4 | MW | 1 | 6b, 39% | 7b/8b, 32% (84:16) | 71% |
3 | 4c | p-ClC6H4 | Batch | 8 | 6c, 49% | 7c/8c, 38% (71:29) | 87% |
4 | 4c | p-ClC6H4 | MW | 1 | 6c, 41% | 7c/8c, 29% (90:10) | 70% |
5 | 4d | p-BrC6H4 | Batch | 2 | 6d, 49% | 7d/8d, 43% (65:35) | 92% |
6 | 4d | p-BrC6H4 | MW | 1 | 6d, 44% | 7d/8d, 33% (58:42) | 77% |
7 | 4e | p-NO2C6H4 | Batch | 2 | 6e, 54% | 7e/8e, 35% (34:66) | 98% |
8 | 4e | p-NO2C6H4 | MW | 1 | 6e, 47% | 7e/8e, 32% (50:50) | 79% |
9 | 4f | p-MeC6H4 | Batch | 5 | 6f, 50% | 7f/8f, 38% (68:32) | 88% |
10 | 4f | p-MeC6H4 | MW | 1 | 6f, 31% | 7f/8f, 20% (85:15) | 51% |
11 | 4g | p-MeOC6H4 | Batch | 0.5 | 6g/8g, 52% (69:31) | 52% | |
12 | 4g | p-MeOC6H4 | MW | 0.25 | 6g/8g, 36% (69:31) | 7g, 21% | 57% |
13 | 4h | Cy | Batch | 6 | 6h, 79% | 7h/8h, 15% (17:83) | 94% |
14 | 4h | Cy | MW | 1 | 6h, 60% | 7h/8h, 10% (10:90) | 70% |
The reaction of alkylidenepenicillanate 5 with nitrile oxide 4b (R = p-FC6H4) under conventional heating was highly selective, leading to the exclusive formation of a single product (6b) in 72% yield (entry 1). On the other hand, performing the same reaction under microwave irradiation (entry 2) led to the synthesis of the same spiro-β-lactam 6b (39% yield) together with spiro-β-lactams 7b/8b (32% yield). Carrying out the cycloaddition reaction with p-chloro or p-bromo substituted nitrile oxides (4c and 4d, respectively) the corresponding spiroisoxazoline-β-lactams 6 (6c and 6d) were obtained as major products under both methodologies in yields ranging from 41% to 49% (entries 3–6). From these reactions, mixtures of isomeric compounds 7c/8c and 7d/8d were also obtained leading to overall yields up to 92% (entries 3–6). The cycloaddition reaction of nitrile oxide 4e, bearing a nitro group at the para position of the aromatic ring, with alkylidenepenicillanate 5 was also explored under the optimized conditions (entries 7 and 8). This reaction allowed the synthesis of 6e as major product in 54% yield under conventional heating (entry 7) as well as under microwave conditions, with compound 6e being obtained in 47% yield (entry 8). In both reactions, mixture of compounds 7e/8e were also obtained in 32–35% yield (entries 7 and 8). Notably, concerning the overall yields, the 1,3-dipolar cycloaddition reaction between 4e and 5 was the most efficient under both conventional heating and microwave irradiation (overall yields: 98% and 79%, respectively).
The cycloaddition reaction of spiro-β-lactam 5 with para-methyl derivative 4f also afforded the expected major spiroisoxazoline-β-lactam 6f in 50% yield under conventional heating (entry 9), together with spiro-β-lactams 7f/8f (38% yield). However, under microwave irradiation (entry 10) the overall yield of this reaction was modest, leading to compounds 6f and 7f/8f in 31% and 20% yield, respectively.
The 1,3-dipolar cycloaddition using as 1,3-dipole nitrile oxide 4g, bearing a stronger electron-donating group (R = p-MeOC6H4), was extremely fast under conventional heating (15 minutes) leading to an inseparable mixture of 6g/8g in 52% yield (entry 11). Under microwave irradiation for 30 minutes the same mixture (6g/8g) was isolated in 36% yield, together with pure spiro-β-lactam 7g obtained in 20% yield (entry 12).
The synthesis of spiroisoxazoline-β-lactams derived from an alkyl-substituted nitrile oxide were also explored (entries 13 and 14). Under conventional heating, the 1,3-dipolar cycloaddition reaction of dipole 4h, bearing a cyclohexyl moiety, with alkylidenepenicillanate 5 led to pure spiroisoxazoline-β-lactam 6h in an exceptional yield of 79%. The formation of 7h/8h was also observed in 15% yield. Conducting the same reaction under microwave irradiation allowed the synthesis of compound 6h in 60% yield, together with the mixture of 7h/8h isolated in low yield (10%). It should be noted that this cycloaddition was highly selective for the synthesis of spiro-β-lactam 6h and the yields were comparable with the ones observed in the cycloaddition of spiro-β-lactam 5 with aryl-substituted nitrile oxides.
Briefly, both methodologies led to pure chiral spiroisoxazoline-β-lactams 6a–h (with exception of 6g which is obtained in a mixture with 8g). To our surprise, the reaction under microwave irradiation took longer than expected, and in most cases, there were no substantial differences regarding reaction times using conventional heating or microwave irradiation. In addition, we should highlight the synthesis of spiro-β-lactams 6 in higher yields under conventional heating (conventional heating: 49–79% vs. microwave irradiation: 31–60%) as well as higher overall yields (conventional heating: 52–98% vs. microwave irradiation: 51–79%).
Thus, we have extended our efforts to the development of a continuous flow approach to chiral spiroisoxazoline-penicillanates via 1,3-dipolar cycloaddition reaction of alkylidenepenicillanate 5 to nitrile oxides 4 (Table 3). The approach for the dehydrohalogenation of hydroximoyl chlorides 3 leading to the in situ generation of the corresponding nitrile oxides 4, relied on the use of a packed-bed reactor filled with fresh potassium carbonate.
Entry | 4 | R | Isolated yields (ratio)a | Overall yields | |
---|---|---|---|---|---|
a Ratio determined by 1H NMR.b 50 μL min−1 flow rate, tR = 24 min.c Reaction carried out at 80 °C.d 4 equiv. of the nitrile oxide. | |||||
1 | 4a | C6H5 | 6a, 54% | 7a/8a, 35% (33:67) | 89% |
2 | 4a b | C6H5 | 6a, 50% | 7a/8a, 45% (45:55) | 95% |
3 | 4a c | C6H5 | 6a, 10% | — | 10% |
4 | 4a c,d | C6H5 | 6a, 22% | — | 22% |
5 | 4b | p-FC6H4 | 6b, 49% | 7b/8b, 38% (53:47) | 87% |
6 | 4c | p-ClC6H4 | 6c, 45% | 7c/8c, 29% (65:35) | 74% |
7 | 4d | p-BrC6H4 | 6d, 57% | 7d/8d, 35% (75:25) | 92% |
8 | 4f | p-MeC6H4 | 6f, 51% | 7f/8f, 23% (39:61) | 74% |
9 | 4g | p-MeOC6H4 | 6g/8g, 54% (51:49) | 54% | |
10 | 4h | Cy | 6h, 40% | 7h/8h, 3% (39:61) | 43% |
The set-up was composed of two inlets, one containing a solution of 6-(Z)-(benzoylmethylidene)penicillanate 5 and another one containing a solution of the appropriate hydroximoyl chloride 3, with both solutions being mixed right before entering the packed-bed reactor. Carrying out the reaction of alkylidene 5 with 1,3-dipole 4a at room temperature with a flow rate of 100 μL min−1 of each solution led to the expected spirocyclic compounds, in 89% overall yield, with the major compound 6a being obtained in 54% yield (Table 3, entry 1). The reaction conditions were then optimized. The influence of the residence time, tR, was investigated by tuning the flow rates of reagents (entry 2). Decreasing the flow rate of each solution to 50 μL min−1, an improvement on the overall yield was observed (95%), however, with a slight decrease in the yield of the major compound 6a (50%). Unlike what was observed for reactions carried out in batch or under microwave irradiation, the increase of the temperature to 80 °C under flow conditions did not lead to better results even with the simultaneous increase of nitrile oxide equivalents (entries 3 and 4). Considering the above-presented results, we selected a flow rate of 100 μL min−1, together with room temperature and 2 equiv. of the nitrile oxide as the best conditions to continue our studies.
Next, continuous flow 1,3-dipolar cycloaddition of 6-(Z)-(benzoylmethylidene)penicillanate 5 to nitrile oxides 4b–h was explored (Table 3, entries 5–10). Using p-halophenyl-nitrile oxides (R = F, Cl, Br) the expected spiro-β-lactams were obtained in excellent overall yields, ranging from 74% to 92% (entries 5–7). Chiral spiro-β-lactam 6b, 6c and 6d were obtained as major products in 49%, 45% and 57%, respectively. The continuous flow also proved to be a viable approach for the synthesis of spiroisoxazoline-penicillanates using nitrile oxides containing electron-donating groups at the phenyl para-position, giving the expected cycloadducts in yields as good as under conventional heating (entries 8 and 9). Unfortunately, among the set of aryl-substituted nitrile oxides used in the present work it was not possible to study the behavior of nitrile oxide 4e (R = p-NO2C6H4) under flow conditions due to its partial insolubility in a wide range of solvents.
Finally, the 1,3-dipolar cycloaddition of alkyl-substituted dipole 4h was studied. In this case, the major spirocyclic adduct 6h was obtained in moderate yield (40%) together with a mixture of 7h/8h (39:61 ratio) in 3% yield. Thus, the synthesis of chiral spiroisoxazoline-penicillanates 6h/7h/8h under continuous flow conditions proved to be less efficient than under conventional heating or microwave irradiation.
These results have shown that continuous flow is an interesting alternative approach to the other methodologies discussed in the present work, to carry out 1,3-dipolar cycloaddition reactions leading to spiro isoxazoline penicillanates. It is noteworthy that the continuous flow technique allowed the synthesis of the target compounds with a very short reaction time (tR = 12 minutes) having the great advantage of enabling easy scale-up processes. In fact, as outlined in Fig. 3, continuous flow proved to be the best methodology for the synthesis of the major spiro-β-lactams 6 with production rates ranging from 200 to 400 mg h−1, values considerably higher than the ones observed for batch and microwave-induced methodologies.
It was demonstrated that these spirocyclic adducts could be obtained using three different methodologies: conventional heating, microwave irradiation and continuous flow. Both conventional heating and continuous flow proved to be better approaches than the microwave-induced methodology leading to the major product in higher yields (conventional heating: 49–79%; continuous flow: 40–57%), and in high overall yields (conventional heating: 52–98%; continuous flow: 43–92%). Nevertheless, the continuous flow 1,3-dipolar cycloaddition reaction stands out for allowing very short reaction times, and by its inherent characteristics that ensure easy scale-up processes. In this study it was possible to observe that continuous flow conditions led to higher production rates than batch or microwave-induced methodologies, with the major products being obtained in up to 400 mg h−1.
3a: mp 45.1–47.1 °C (lit.20 47–48 °C); 1H NMR (CDCl3, 400 MHz) δ = 7.40–7.46 (m, 3H), 7.85 (dd, J = 8.1 and 1.5 Hz, 2H), 8.25 (s, 1H). The 1H NMR spectral data are in good agreement with the literature data.21
3b: mp 75.1–77.1 °C (lit.22 74.5–75 °C); 1H NMR (CDCl3, 400 MHz) δ = 7.10 (t, J = 8.7 Hz, 2H), 7.84 (dd, J = 9.0 and 5.3 Hz, 2H), 7.91 (s, 1H). The 1H NMR spectral data are in good agreement with the literature data.23
3c: mp 86.4–88.4 °C (lit.20 88.5–89.5 °C); 1H NMR (CDCl3, 400 MHz) δ = 7.39 (d, J = 8.8 Hz, 2H), 7.79 (d, J = 8.8 Hz, 2H), 27.96 (s, 1H). The 1H NMR spectral data are in good agreement with the literature data.24
3d: mp 78.3–80.3 °C (lit.25 76–78 °C); 1H NMR (CDCl3, 400 MHz) δ = 7.55 (d, J = 8.7 Hz, 2H), 7.72 (d, J = 8.7 Hz, 2H), 7.84 (s, 1H). The 1H NMR spectral data are in good agreement with the literature data.23
3e: mp 121.4–123.4 °C (lit.20 124–125 °C); 1H NMR (CDCl3, 400 MHz) δ = 8.05 (d, J = 9.0 Hz, 2H), 8.27 (d, J = 9.0 Hz, 2H), 8.32 (s, 1H). The 1H NMR spectral data are in good agreement with the literature data.23
3f: mp 67.4–69.4 °C (lit.26 71–72 °C); 1H NMR (CDCl3, 400 MHz) δ = 2.38 (s, 3H), 7.21 (d, J = 8.1 Hz, 2H), 7.65 (s, 1H), 7.73 (d, J = 8.3 Hz, 2H). The 1H NMR spectral data are in good agreement with the literature data.24
3g: mp 85.7–87.7 °C (lit.20 87.5–89 °C); 1H NMR (CDCl3, 400 MHz) δ = 3.85 (s, 3H), 6.91 (d, J = 9.0 Hz, 2H), 7.65 (s, 1H), 7.79 (d, J = 9.0 Hz, 2H). The 1H NMR spectral data are in good agreement with the literature data.27
3h: 1H NMR (CDCl3, 400 MHz) δ = 1.23–1.35 (m, 1H), 1.39–1.50 (m, 2H), 1.66–1.70 (m, 1H), 1.78–1.82 (m, 2H), 1.92–1.96 (m, 2H), 2.46 (tt, J = 11.5 and 3.4 Hz, 1H), 8.10 (s, 1H). The 1H NMR spectral data are in good agreement with the literature data.28
6a: mp 74.0–76.0 °C; [α]25D = +360 (c 0.5 in CH2Cl2); IR (ATR): ν = 881, 1083, 1156, 1449, 1496, 1586, 1678, 1740 and 1780 cm−1; 1H NMR (CDCl3, 400 MHz) δ = 1.15 (s, 3H), 1.57 (s, 3H), 4.65 (s, 1H), 5.86 (s, 1H), 6.17 (s, 1H), 6.98 (s, 1H), 7.27–7.35 (m, 12H), 7.43 (t, J = 7.5 Hz, 1H), 7.52–7.56 (m, 2H), 7.66 (t, J = 7.4 Hz, 1H), 7.81–7.83 (m, 2H), 8.04–8.06 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ = 26.2, 32.1, 63.7, 68.0, 69.9, 76.6, 78.8, 81.8, 126.7, 127.3, 127.4, 127.5, 127.7, 128.5, 128.6, 128.6, 128.8, 128.9, 129.1, 129.2, 129.4, 131.0, 134.5, 135.0, 139.1, 139.2, 155.6, 166.5, 170.7, 191.6; HRMS (ESI) m/z: calcd for C36H31N2O5S [M + H]+ 603.1948; found 666.1941.
7a: mp low melting solid; [α]25D = +280 (c 0.25 in CH2Cl2); IR (ATR): ν = 910, 1080, 1176, 1448, 1497, 1595, 1676, 1741 and 1777 cm−1; 1H NMR (400 MHz, CDCl3): δ = 1.12 (s, 3H), 1.46 (s, 3H), 4.60 (s, 1H), 5.67 (s, 1H), 5.68 (s, 1H), 6.93 (s, 1H), 7.22–7.24 (m, 2H), 7.30–7.35 (m, 11H), 7.48–7.55 (m, 4H), 7.63 (t, J = 7.4 Hz, 1H), 7.95–7.97 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 25.5, 33.4, 57.9, 63.7, 68.9, 72.9, 77.5, 78.7, 102.2, 127.2, 127.3, 127.5, 127.6, 128.4, 128.6, 128.6, 128.7, 128.8, 128.8, 128.9, 129.0, 129.3, 131.0, 134.5, 137.2, 139.1, 139.1, 156.7, 166.2, 170.3, 194.6; HRMS (ESI) m/z: calcd for C36H31N2O5S [M + H]+ 603.1948; found 666.1945.
Recorded as a mixture of 7a/8a (33:67): 8a: 1H NMR (CDCl3, 400 MHz) δ = 1.30 (s, 3H), 1.33 (s, 3H), 4.46 (s, 1H), 5.56 (s, 1H), 5.79 (s, 1H), 6.93 (s, 1H), 7.22–7.24 (m, 2H), 7.30–7.35 (m, 11H), 7.48–7.55 (m, 4H), 7.63 (t, J = 7.4 Hz, 1H), 8.11 (d, J = 7.2 Hz, 2H).
6b: mp 167.1–169.1 °C; [α]25D = +380 (c 0.5 in CH2Cl2); IR (ATR): ν = 838, 1081, 1156, 1449, 1509, 1598, 1676, 1736 and 1778 cm−1; 1H NMR (CDCl3, 400 MHz) δ = 1.17 (s, 3H), 1.57 (s, 3H), 4.65 (s, 1H), 5.84 (s, 1H), 6.17 (s, 1H), 6.90 (t, J = 8.7 Hz, 2H), 6.98 (s, 1H), 7.30–7.36 (m, 10H), 7.53–7.56 (m, 2H), 7.66 (t, J = 7.4 Hz, 1H), 7.79–7.82 (m, 2H), 8.04–8.06 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ = 26.1, 32.3, 63.8, 68.0, 69.9, 76.6, 78.9, 81.8, 116.5 (d, J = 22 Hz), 123.4 (d, J = 3 Hz), 127.2, 127.7, 128.5, 128.7, 128.8, 128.8, 129.0, 129.2, 129.4, 129.4, 129.5, 134.5, 134.9, 139.0 (d, J = 2 Hz), 154.6, 164.4 (d, J = 252 Hz), 166.5, 170.4, 191.6; 19F NMR (CDCl3, 376 MHz) δ = −108.5 (s, 1F); HRMS (ESI) m/z: calcd for C36H29N2O5FNaS [M + Na]+ 643.1673; found 643.1671.
Recorded as a mixture of 7b/8b (53:47): 7b: 1H NMR (CDCl3, 400 MHz) δ = 1.12 (s, 3H), 1.46 (s, 3H), 4.60 (s, 1H), 5.63 (s, 1H), 5.66 (s, 1H), 6.91–6.96 (3H), 7.30–7.35 (m, 10H), 7.47–7.56 (m, 4H), 7.62–7.66 (m, 1H), 7.93–7.95 (m, 2H); 8b: 1H NMR (CDCl3, 400 MHz) δ = 1.30 (s, 3H), 1.34 (s, 3H), 4.46 (s, 1H), 5.56 (s, 1H), 5.74 (s, 1H), 6.91–6.96 (3H), 7.30–7.35 (m, 10H), 7.47–7.56 (m, 4H), 7.62–7.66 (m, 1H), 8.08–8.10 (m, 2H).
6c: mp 198.1–199.4 °C; [α]25D = +450 (c 0.5 in CH2Cl2); IR (ATR): ν = 975, 1086, 1156, 1203, 1450, 1492, 1595, 1667, 1736 and 1779 cm−1; 1H NMR (CDCl3, 400 MHz) δ = 1.17 (s, 3H), 1.57 (s, 3H), 4.65 (s, 1H), 5.85 (s, 1H), 6.18 (s, 1H), 6.99 (s, 1H), 7.16 (d, J = 8.7 Hz, 2H), 7.31–7.36 (m, 10H), 7.53–7.56 (m, 2H), 7.66 (t, J = 7.4 Hz, 1H), 7.73–7.77 (m, 2H), 8.03–8.05 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ = 26.1, 32.8, 63.8, 68.0, 69.9, 76.5, 79.0, 81.9, 125.7, 127.2, 127.7, 128.6, 128.8, 129.0, 129.2, 129.4, 129.6, 134.6, 134.9, 137.2, 139.0, 154.6, 166.4, 170.4, 191.5; HRMS (ESI) m/z: calcd for C36H29N2O5Cl2S [M + Cl]+ 671.1180; found 671.1183.
Recorded as a mixture of 7c/8c (90:10): 7c: 1H NMR (CDCl3, 400 MHz) δ = 1.12 (s, 3H), 1.46 (s, 3H), 4.60 (s, 1H), 5.64 (s, 1H), 5.67 (s, 1H), 6.93 (s, 1H), 7.21–7.23 (m, 2H), 7.30–7.36 (m, 10H), 7.46–7.53 (m, 4H), 7.62–7.66 (m, 1H), 7.93–7.95 (m, 2H); 8c: 1H NMR (CDCl3, 400 MHz) δ = 1.30 (s, 3H), 1.34 (s, 3H), 4.46 (s, 1H), 5.56 (s, 1H), 5.74 (s, 1H), 6.93 (s, 1H), 7.21–7.23 (m, 2H), 7.30–7.36 (m, 10H), 7.46–7.53 (m, 4H), 7.62–7.66 (m, 1H), 8.07–8.09 (m, 2H).
6d: mp 196.7–198.4 °C; [α]25D = +410 (c 0.5 in CH2Cl2); IR (ATR): ν = 866, 1086, 1155, 1203, 1450, 1492, 1594, 1667, 1736 and 1779 cm−1; 1H NMR (CDCl3, 400 MHz) δ = 1.18 (s, 3H), 1.57 (s, 3H), 4.65 (s, 1H), 5.86 (s, 1H), 6.18 (s, 1H), 6.90 (t, J = 8.7 Hz, 2H), 6.96 (s, 1H), 7.30–7.37 (m, 10H), 7.53–7.56 (m, 2H), 7.65–7.70 (m, 3H), 8.03–8.06 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ = 26.1, 32.4, 63.8, 68.0, 69.9, 76.5, 79.0, 81.9, 125.7, 126.2, 127.2, 127.7, 128.6, 128.7, 128.8, 129.0, 129.2, 129.4, 132.5, 134.6, 134.9, 139.0, 154.6, 166.4, 170.4, 191.5; HRMS (ESI) m/z: calcd for C36H30N2O5BrS [M + H]+ 681.1053; found 681.1049.
Recorded as a mixture of 7d/8d (58:42): 7d: 1H NMR (CDCl3, 400 MHz) δ = 1.12 (s, 3H), 1.46 (s, 3H), 4.60 (s, 1H), 5.64 (s, 1H), 5.66 (s, 1H), 6.93 (s, 1H), 7.31–7.35 (m, 10H), 7.38–7.40 (m, 3H), 7.47–7.53 (m, 3H), 7.63–7.66 (m, 1H), 7.93–7.95 (m, 2H); 8d: 1H NMR (CDCl3, 400 MHz) δ = 1.30 (s, 3H), 1.34 (s, 3H), 4.46 (s, 1H), 5.56 (s, 1H), 5.73 (s, 1H), 6.94 (s, 1H), 7.31–7.35 (m, 10H), 7.38–7.40 (m, 3H), 7.47–7.53 (m, 3H), 7.63–7.66 (m, 1H), 8.07–8.09 (m, 2H).
6e: mp 171.7.-173.7 °C; [α]25D = +370 (c 0.5 in CH2Cl2); IR (ATR): ν = 884, 1082, 1155, 1344, 1449, 1497, 1518, 1597, 1669, 1744 and 1777 cm−1; 1H NMR (CDCl3, 400 MHz) δ = 1.20 (s, 3H), 1.58 (s, 3H), 4.68 (s, 1H), 5.88 (s, 1H), 6.25 (s, 1H), 7.00 (s, 1H), 7.33–7.38 (m, 10H), 7.54–7.58 (m, 2H), 7.69 (t, J = 7.4 Hz, 1H), 7.98–8.06 (m, 6H); 13C NMR (CDCl3, 100 MHz) δ = 26.1, 32.5, 64.0, 67.9, 69.9, 76.4, 79.2, 82.3, 124.4, 127.1, 127.8, 128.2, 128.6, 128.8, 128.8, 128.9, 128.9, 129.0, 129.3, 129.4, 133.4, 134.8, 138.8, 149.1, 153.8, 166.3, 169.9, 191.4; HRMS (ESI) m/z: calcd for C36H30N3O7S [M + H]+ 648.1799; found 648.1792.
Recorded as a mixture of 7e/8e (50:50): 7e: 1H NMR (CDCl3, 400 MHz) δ = 1.13 (s, 3H), 1.46 (s, 3H), 4.61 (s, 1H), 5.69 (s, 1H), 5.72 (s, 1H), 6.94 (s, 1H), 7.31–7.36 (m, 10H), 7.48–7.56 (m, 2H), 7.76–7.78 (m, 2H), 8.08–8.12 (m, 2H), 8.18–8.20 (m, 2H), 8.33–8.36 (m, 1H); 8e: 1H NMR (CDCl3, 400 MHz) δ = 1.31 (s, 3H), 1.33 (s, 3H), 4.47 (s, 1H), 5.58 (s, 1H), 5.82 (s, 1H), 6.94 (s, 1H), 7.31–7.36 (m, 10H), 7.48–7.56 (m, 2H), 7.69–7.72 (m, 2H), 7.94–7.96 (m, 2H), 8.08–8.12 (m, 2H), 8.33–8.36 (m, 1H).
6f: mp 88.4–90.4 °C; [α]25D = +420 (c 0.5 in CH2Cl2); IR (ATR): ν = 876, 1156, 1449, 1497, 1596, 1676, 1742 and 1774 cm−1; 1H NMR (CDCl3, 400 MHz) δ = 1.16 (s, 3H), 1.56 (s, 3H), 2.34 (s, 3H), 4.65 (s, 1H), 5.88 (s, 1H), 6.16 (s, 1H), 6.98 (s, 1H), 7.04 (d, J = 8.0 Hz, 2H), 7.26–7.36 (m, 10H), 7.52–7.55 (m, 2H), 7.65 (t, J = 7.4 Hz, 1H), 7.72 (d, J = 8.2 Hz, 2H), 8.04–8.06 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ = 21.6, 26.2, 32.1, 63.6, 68.0, 69.8, 76.6, 78.8, 81.6, 124.4, 127.3, 127.3, 127.6, 128.5, 128.5, 128.8, 128.9, 129.1, 129.4, 130.0, 134.4, 135.0, 139.1, 139.2, 141.3, 155.5, 166.6, 170.7, 191.6; HRMS (ESI) m/z: calcd for C37H33N2O5S [M + H]+ 617.2105; found 617.2098.
Recorded as a mixture of 7f/8f (85:15): 7f: 1H NMR (CDCl3, 400 MHz) δ = 1.12 (s, 3H), 1.46 (s, 3H), 2.27 (s, 3H), 4.59 (s, 1H), 5.66 (s, 1H), 5.66 (s, 1H), 6.93 (s, 1H), 7.04 (d, J = 8.1 Hz, 2H), 7.30–7.35 (m, 10H), 7.43 (d, J = 8.2 Hz, 2H), 7.46–7.52 (m, 2H), 7.62 (t, J = 7.4 Hz, 1H), 7.94–7.96 (m, 2H); 8f: 1H NMR (CDCl3, 400 MHz) δ = 1.30 (s, 3H), 1.34 (s, 3H), 2.32 (s, 3H), 4.46 (s, 1H), 5.56 (s, 1H), 5.75 (s, 1H), 6.93 (s, 1H), 7.13 (d, J = 8.1 Hz, 2H), 7.30–7.35 (m, 10H), 7.42–7.44 (m, 2H), 7.46–7.52 (m, 2H), 7.56–7.58 (m, 1H), 8.09 (d, J = 7.3 Hz, 2H).
Recorded as a mixture of 6g/8g (69:31): 6g: 1H NMR (CDCl3, 400 MHz) δ = 1.16 (s, 3H), 1.57 (s, 3H), 3.78 (s, 3H), 4.65 (s, 1H), 5.89 (s, 1H), 6.15 (s, 1H), 6.76 (d, J = 8.9 Hz, 2H), 6.99 (s, 1H), 7.31–7.36 (m, 10H), 7.51–7.55 (m, 2H), 7.63–7.65 (m, 1H), 7.78–7.80 (m, 2H), 8.03–8.06 (m, 2H); 8g: 1H NMR (CDCl3, 400 MHz) δ = 1.16 (s, 3H), 1.57 (s, 3H), 3.86 (s, 3H), 4.66 (s, 1H), 5.89 (s, 1H), 6.16 (s, 1H), 6.65 (d, J = 8.9 Hz, 1H), 6.99 (s, 1H), 7.31–7.36 (m, 10H), 7.51–7.55 (m, 2H), 7.63–7.65 (m, 1H), 7.75 (dd, J = 8.9 and 2.2 Hz, 2H), 7.90 (d, J = 2.2 Hz, 1H), 8.03–8.06 (m, 2H).
7g: mp 94.3–96.3 °C; [α]25D = +260 (c 0.25 in CH2Cl2); IR (ATR): ν = 911, 1717, 1256, 1457, 1516, 1607, 1740 and 1781 cm−1; 1H NMR (CDCl3, 400 MHz) δ = 1.12 (s, 3H), 1.46 (s, 3H), 3.75 (s, 3H), 4.60 (s, 1H), 5.62 (s, 1H), 5.65 (s, 1H), 6.74 (d, J = 8.9 Hz, 2H), 6.92 (s, 1H), 7.30–7.35 (m, 10H), 7.47–7.51 (m, 4H), 7.62 (t, J = 7.4 Hz, 1H), 7.94–7.96 (m, 2H);13C NMR (CDCl3, 100 MHz) δ = 25.5, 33.4, 55.4, 58.5, 63.7, 68.9, 72.9, 78.7, 101.9, 114.4, 119.7, 127.3, 127.6, 128.4, 128.6, 128.7, 128.8, 128.8, 129.2, 129.3, 134.4, 137.2, 139.1, 139.1, 156.3, 161.7, 166.2, 170.5, 194.6; HRMS (ESI) m/z: calcd for C37H33N2O6S [M + H]+ 633.2054; found 633.2048.
6h: mp 182.7–185.0 °C; [α]25D = +340 (c 0.25 in CH2Cl2); IR (ATR): ν = 882, 1154, 1176, 1450, 1495, 1597, 1668, 1746, 1773, 2856 and 2390 cm−1; 1H NMR (CDCl3, 400 MHz) δ = 1.19 (s, 3H), 1.22–1.26 (m, 3H), 1.53 (s, 3H), 1.61–1.79 (m, 5H), 1.97–2.00 (m, 2H), 2.47 (tt, J = 11.4 and 3.3 Hz, 1H), 4.59 (s, 1H), 5.84 (s, 1H), 5.94 (s, 1H), 6.97 (s, 1H), 7.32–7.38 (m, 10H), 7.49–7.53 (m, 2H), 7.63 (t, J = 7.4 Hz, 1H), 7.99–8.01 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ = 25.8, 26.0, 26.0, 26.2, 31.4, 31.9, 32.7, 36.1, 63.6, 68.0, 70.0, 78.2, 78.7, 80.0, 127.2, 127.6, 128.5, 128.7, 128.8, 128.9, 129.0, 129.4, 134.3, 135.1, 139.1, 139.3, 160.8, 166.5, 170.7, 192.0; HRMS (ESI) m/z: calcd for C36H37N2O5S [M + H]+ 609.2418; found 609.2413.
Recorded as a mixture of 7h/8h (10:90): 7h: 1H NMR (CDCl3, 400 MHz) δ = 1.10 (s, 3H), 1.38 (s, 3H), 1.40–1.88 (m, 10H), 2.03–2.10 (m, 1H), 4.40 (s, 1H, 5.40 (s, 1H), 5.46 (s, 1H), 6.91 (s, 1H), 7.29–7.36 (m, 10H), 7.53 (t, J = 7.8 Hz, 2H), 7.66 (t, J = 7.4 Hz, 1H), 7.95–7.97 (m, 2H); 8h: 1H NMR (CDCl3, 400 MHz) δ = 1.10 (s, 3H), 1.38 (s, 3H), 1.40–1.88 (m, 10H), 2.03–2.10 (m, 1H), 4.53 (s, 1H), 5.25 (s, 1H), 5.62 (s, 1H), 6.91 (s, 1H), 7.29–7.36 (m, 10H), 7.46–7.50 (m, 2H), 7.60 (t, J = 7.4 Hz, 1H), 8.02 (d, J = 7.2 Hz, 2H).
Footnote |
† Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d2ra04848e |
This journal is © The Royal Society of Chemistry 2022 |